£104.34

This is the most expensive it has ever been. Walk away.

£104 today · previous high £104 · all-time low £100

Humana Renal Cell Carcinoma: Clinical Management: 0 (Current Clinical Urology)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 36 days · 36 data points (no recent data)

Historical
Generating forecast…
£104.34 £99.57 £100.61 £101.65 £102.69 £103.73 £104.77 11 August 2026 19 August 2026 28 August 2026 06 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 55 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 36 days • 2 price levels

Days at Price
Current Price
12 days 24 days · current 0 6 12 18 24 £100 £104 Days at Price

Price Analysis

Most common price: £104 (24 days, 66.7%)

Price range: £100 - £104

Price levels: 2 different prices over 36 days

Description

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
26 September 2012
Listed Since
27 April 2012

Barcode

No barcode data available

Similar Products You Might Like

Management of Castration Resistant Prostate Cancer (Current Clinical Urology)
88% match

Management of Castration Resistant Prostate Cancer (Current Clinical Urology)

Humana

£104.33 29 Aug 2026
Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)
88% match

Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)

Humana

£113.76 24 Oct 2026
Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)
87% match

Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)

Elsevier

£69.11 13 Sep 2026
Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments
87% match

Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments

Springer

£76.42 15 Sep 2026
Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)
86% match

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)

Humana

£80.65 22 Oct 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
85% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.65 22 Oct 2026
Integrated Approach to Renal Cell Carcinoma
85% match

Integrated Approach to Renal Cell Carcinoma

Foster Academics

£49.22 14 Sep 2026
Advances in the Treatment of Renal Cell Carcinoma
84% match

Advances in the Treatment of Renal Cell Carcinoma

£41.90 14 Sep 2026
Renal Cancer: Contemporary Management
84% match

Renal Cancer: Contemporary Management

Springer

£103.26 02 Sep 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
84% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£80.67 24 Oct 2026
Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management (Current Clinical Urology)
84% match

Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management (Current Clinical Urology)

Humana

£88.21 27 Oct 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
83% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.67 02 Nov 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
83% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£156.70 30 Oct 2026
Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)
83% match

Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)

Springer

£85.67 26 Oct 2026
Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)
83% match

Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)

Springer

£76.42 15 Sep 2026
Carcinoma of the Bladder: Innovations in Management (Medical Radiology)
83% match

Carcinoma of the Bladder: Innovations in Management (Medical Radiology)

Springer

£77.49 27 Oct 2026
Advances in the Treatment of Kidney and Upper Urinary Tract Cancers
83% match

Advances in the Treatment of Kidney and Upper Urinary Tract Cancers

£52.78 15 Sep 2026
Urothelial Carcinoma: Methods and Protocols: 1655 (Methods in Molecular Biology, 1655)
83% match

Urothelial Carcinoma: Methods and Protocols: 1655 (Methods in Molecular Biology, 1655)

Humana

£80.67 24 Oct 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
83% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£41.40 23 Oct 2026
Carcinoma of the Prostate: Innovations in Management (Medical Radiology)
83% match

Carcinoma of the Prostate: Innovations in Management (Medical Radiology)

Springer

£77.49 30 Oct 2026
Cancer Gene Therapy (Contemporary Cancer Research)
83% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£166.07 24 Oct 2026
Modern Management of Cancer of the Rectum
82% match

Modern Management of Cancer of the Rectum

Springer

£72.71 29 Aug 2026
Robotic Renal Surgery: Benign and Cancer Surgery for the Kidneys and Ureters
82% match

Robotic Renal Surgery: Benign and Cancer Surgery for the Kidneys and Ureters

Springer

£61.84 24 Oct 2026
Protein Kinase C in Cancer Signaling and Therapy (Current Cancer Research)
82% match

Protein Kinase C in Cancer Signaling and Therapy (Current Cancer Research)

Humana

£146.88 29 Aug 2026